Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

NCT01462942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2443

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Aclidinium Bromide/Formoterol Fumarate
DRUG: Aclidinium Bromide/Formoterol Fumarate
DRUG: Aclidinium Bromide
DRUG: Placebo
DRUG: Formoterol Fumarate

Sponsor

AstraZeneca